Clinical Trial Update: Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

View source ↗

Summary

This clinical trial update reports real-world use of deucravacitinib for moderate-to-severe psoriasis in Italy, with ongoing recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Status: RECRUITING